Diabetes and Endocrinology Consultants of Pennsylvania, LLC | Feasterville, PA

Research site

Location

1234 Bridgetown Pike, Suite 310, Feasterville, Pennsylvania, United States of America

Site insights

Top conditions

Top treatments

Lorcaserin HCl

BELVIQ

Tirzepatide

LY3298176

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Nancy Ward

Verified by this site

Active trials

2 of 9 total trials

A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes (SURPASS-CVOT)

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardio...

Active, not recruiting

Type 2 Diabetes Mellitus

Drug: Tirzepatide

Drug: Dulaglutide

Post Approval Study of the Eversense® Continuous Glucose Monitoring (PAS)

A Post Approval Study to Evaluate the Long-term Safety and Effectiveness of the Eversense® Continuous Glucose Monitoring (CGM) System over repeat ins...

Active, not recruiting

Diabetes Mellitus, Type 1

Diabetes Mellitus

Device: Eversense® CGM system